NKore Biotherapeutics

Congratulations to one of our founders and CCO Tracy Ryan and our new CSO Farahnaz Forozan, Ph.D., MB(ASCP) for a job well done speaking at the Congressional Pediatric Cancer Caucus on Capitol Hill by invitation of the founder Congressmen Michael McCaul and Representatives Michael McCaul, Mike Kelly, Kathy Castor, and Ami Bera. While Tracy shared her journey with her daughter Sophie that led to the formation of NKore, and gave an update on some of our patients that have received our therapy, Farahnaz dug deeper into the science behind our natural killer cell immunotherapy, and pediatric cancer challenges as a whole. Our documentary film crew that has been following this journey since December was on hand to capture all of the highlights. Job well done ladies!

We are thrilled to announce that Farahnaz Forozan, Ph.D., MB(ASCP) has joined NKore Biotherapeutics biotherapeutics as our Chief Scientific Officer. With her extensive expertise, Farahnaz Forozan, Ph.D., MB(ASCP) Forozan will play a pivotal role in our journey towards FDA approval for our innovative NK101 immunotherapy, which harnesses the power of Supercharged Natural Killer Cells. Dr. Forozan brings over 20 years of global experience in the life sciences sector, having significantly contributed to the development and launch of more than 15 marketed products and 30 global programs. Her leadership experience at pharmaceutical leaders like Bristol Myers Squibb will be invaluable as we advance a new era in immunotherapeutics. Welcome aboard, Dr. Forozan! We look forward to achieving groundbreaking milestones together.

If you missed our co-founder Tracy Ryan’s spotlight on CBS News LA, click below! This piece covers the family’s 11 year long journey with their daughter Sophie, who was diagnosed with a low-grade brain to at 8 1/2 months old, and their fight to save her from any more toxic therapies! She failed 8 protocols including extremely toxic combinations of multiple chemotherapies. Tracy cofounded NKore Biotherapeutics along side Dr. Anahid Jewett and their two other partners with the goal of saving Sophie, and many other patients stricken with cancer and other immune related diseases. https://lnkd.in/gFWMD4Qs

Tune in to KCAL CBS News TONIGHT at 11pm PST and tomorrow morning at 7am to watch an incredible segment on our family journey to save my daughter Sophie! After failing 8 different toxic therapies for her low-grade brain tumor we were able to take over Sophie’s care in 2021 when we started giving her non-toxic Natural Killer Cells. These cells are the main drivers of your immune system and Sophie was born with zero in her brain. A discovery my business partner, and world renowned and cancer research immunotherapy research scientist Dr. Anahid Jewett made when studying Sophie‘s brain fluid. Together she and I started NKore Biotherapeutics with two other partners with the goal of helping both pediatric and adult patients with all forms of cancer, and other life threatening diseases, by repairing their broken immune systems. We have now treated 3 patients, Sophie being the second, and thus far the results have been exactly what we had hoped for! More patients will be treated in July and we hope to file with the FDA for larger scale trials in September.#immunotherapy #naturalkillercells #braincancer #pediatriccancer

Tune in to KCAL CBS News TONIGHT at 11pm PST and tomorrow morning at 7am to watch an incredible segment on our family journey to save my daughter Sophie! After failing 8 different toxic therapies for her low-grade brain tumor we were able to take over Sophie’s care in 2021 when we started giving her non-toxic Natural Killer Cells. These cells are the main drivers of your immune system and Sophie was born with zero in her brain. A discovery my business partner, and world renowned and cancer research immunotherapy research scientist Dr. Anahid Jewett made when studying Sophie‘s brain fluid. Together she and I started NKore Biotherapeutics with two other partners with the goal of helping both pediatric and adult patients with all forms of cancer, and other life threatening diseases, by repairing their broken immune systems. We have now treated 3 patients, Sophie being the second, and thus far the results have been exactly what we had hoped for! More patients will be treated in July and we hope to file with the FDA for larger scale trials in September. To help support our pediatric patients with out of pocket expenses you can donate to www.savingsophie.org. #immunotherapy #naturalkillercells #braincancer #pediatriccancer

The NKore team enjoyed the Innate Killer Summit in San Diego, CA where top researchers from around the world presented on advancements in the field of NK cell therapy. From left to right is Dr. Aneel Paulus from Mayo Clinic who’s on NKore’s medical advisory board, co-founder and chief communications officer Tracy Ryan, one of NKore’s top scientists Dr. Sara Huerta-Yepez, and co-founder and CEO Greg Brophy.